News
The Ampersand Agency has appointed Katie Blagden and Abigail Fenton as new literary agents to work alongside founder Peter ...
AstraZeneca’s anselamimab has failed to show any benefit in patients with light chain amyloidosis in two Phase III trials. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback